Ocean Biomedical, Inc.
PNK: OCEA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Inderjote Kathuria
- Employees
- 7
- Headquarters
- Providence, United States
- IPO year
- 2021
- Market cap
- $118.6K
- Website
- http://www.oceanbiomedical.com
Loading OCEA…
Loading profile data…Frequently asked questions about OCEA
What does Ocean Biomedical, Inc. (OCEA) do?
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung ca...
Where does OCEA trade?
Ocean Biomedical, Inc. (OCEA) trades on the Other OTC.
What sector is OCEA in?
Ocean Biomedical, Inc. (OCEA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ocean Biomedical, Inc.?
Inderjote Kathuria is the chief executive officer of Ocean Biomedical, Inc. (OCEA).
Where is Ocean Biomedical, Inc. headquartered?
Ocean Biomedical, Inc. is headquartered in United States.
Does OCEA pay a dividend?
Ocean Biomedical, Inc. (OCEA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OCEA go public?
Ocean Biomedical, Inc. (OCEA) completed its initial public offering in 2021.